Amyloid monoclonal antibody (investigational)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Amyloid monoclonal antibody (investigational), covering 2026-04-22 to 2026-04-22. Get the full timeline:
Most recent: Clinical Trial Update: Amyloid Monoclonal Antibody Treatment in PD Patients With Coexistent AD Pathology [NA]